United States

Top 538 largest US Companies in the Biotechnology industry by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.

United States Biotechnology Industry Analysis
Top US Companies United States Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies from the United States as of Jan. 01, 2025

Download Excel

Rank Company Market Cap (USD) Country Sector Industry
271 Atossa Therapeutics, Inc. $117.2 M United States US Healthcare US Biotechnology
272 Editas Medicine, Inc. $116.4 M United States US Healthcare US Biotechnology
273 Kinnate Biopharma Inc. $113.5 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
274 XBiotech Inc. $111.3 M United States US Healthcare US Biotechnology
275 Aligos Therapeutics, Inc. $110.9 M United States US Healthcare US Biotechnology
276 NGM Biopharmaceuticals, Inc. $110.8 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
277 Catabasis Pharmaceuticals, Inc. $109.5 M

(June 1, 2022)

United States US Healthcare US Biotechnology
278 Cyteir Therapeutics, Inc. $109.1 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
279 Allakos Inc. $108.1 M United States US Healthcare US Biotechnology
280 Opiant Pharmaceuticals, Inc. $107.5 M

(Jan. 1, 2023)

United States US Healthcare US Biotechnology
281 Entasis Therapeutics Holdings Inc. $104.8 M

(June 1, 2024)

United States US Healthcare US Biotechnology
282 Jounce Therapeutics, Inc. $101.6 M

(May 1, 2023)

United States US Healthcare US Biotechnology
283 Cue Biopharma, Inc. $94.4 M United States US Healthcare US Biotechnology
284 Assembly Biosciences, Inc. $93.9 M United States US Healthcare US Biotechnology
285 Adverum Biotechnologies, Inc. $93.4 M United States US Healthcare US Biotechnology
286 MediciNova, Inc. $92.7 M United States US Healthcare US Biotechnology
287 Osmotica Pharmaceuticals plc $92.5 M

(June 1, 2022)

United States US Healthcare US Biotechnology
288 ALX Oncology Holdings Inc. $91.8 M United States US Healthcare US Biotechnology
289 Oramed Pharmaceuticals Inc. $91.5 M United States US Healthcare US Biotechnology
290 Immunic, Inc. $89.4 M United States US Healthcare US Biotechnology
291 Karyopharm Therapeutics Inc. $88.3 M United States US Healthcare US Biotechnology
292 Werewolf Therapeutics, Inc. $87.3 M United States US Healthcare US Biotechnology
293 Agenus Inc. $84.3 M United States US Healthcare US Biotechnology
294 Inozyme Pharma, Inc. $83.5 M United States US Healthcare US Biotechnology
295 Inovio Pharmaceuticals, Inc. $82.7 M United States US Healthcare US Biotechnology
296 Reviva Pharmaceuticals Holdings, Inc. $82.4 M United States US Healthcare US Biotechnology
297 Leap Therapeutics, Inc. $82.4 M United States US Healthcare US Biotechnology
298 VistaGen Therapeutics, Inc. $82.1 M United States US Healthcare US Biotechnology
299 Ikena Oncology, Inc. $82.0 M United States US Healthcare US Biotechnology
300 X4 Pharmaceuticals, Inc. $81.4 M United States US Healthcare US Biotechnology

Top Biotechnology Companies from the United States as of Jan. 01, 2025

271. Atossa Therapeutics, Inc.

Company Profile: Atossa Therapeutics, Inc.
Market Cap (USD): $117.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

272. Editas Medicine, Inc.

Company Profile: Editas Medicine, Inc.
Market Cap (USD): $116.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

273. Kinnate Biopharma Inc.

Company Profile: Kinnate Biopharma Inc.
Market Cap (USD): $113.5 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

274. XBiotech Inc.

Company Profile: XBiotech Inc.
Market Cap (USD): $111.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

275. Aligos Therapeutics, Inc.

Company Profile: Aligos Therapeutics, Inc.
Market Cap (USD): $110.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

276. NGM Biopharmaceuticals, Inc.

Company Profile: NGM Biopharmaceuticals, Inc.
Market Cap (USD): $110.8 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

277. Catabasis Pharmaceuticals, Inc.

Company Profile: Catabasis Pharmaceuticals, Inc.
Market Cap (USD): $109.5 M (June 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

278. Cyteir Therapeutics, Inc.

Company Profile: Cyteir Therapeutics, Inc.
Market Cap (USD): $109.1 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

279. Allakos Inc.

Company Profile: Allakos Inc.
Market Cap (USD): $108.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

280. Opiant Pharmaceuticals, Inc.

Company Profile: Opiant Pharmaceuticals, Inc.
Market Cap (USD): $107.5 M (Jan. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

281. Entasis Therapeutics Holdings Inc.

Company Profile: Entasis Therapeutics Holdings Inc.
Market Cap (USD): $104.8 M (June 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

282. Jounce Therapeutics, Inc.

Company Profile: Jounce Therapeutics, Inc.
Market Cap (USD): $101.6 M (May 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

283. Cue Biopharma, Inc.

Company Profile: Cue Biopharma, Inc.
Market Cap (USD): $94.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

284. Assembly Biosciences, Inc.

Company Profile: Assembly Biosciences, Inc.
Market Cap (USD): $93.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

285. Adverum Biotechnologies, Inc.

Company Profile: Adverum Biotechnologies, Inc.
Market Cap (USD): $93.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

286. MediciNova, Inc.

Company Profile: MediciNova, Inc.
Market Cap (USD): $92.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

287. Osmotica Pharmaceuticals plc

Company Profile: Osmotica Pharmaceuticals plc
Market Cap (USD): $92.5 M (June 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

288. ALX Oncology Holdings Inc.

Company Profile: ALX Oncology Holdings Inc.
Market Cap (USD): $91.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

289. Oramed Pharmaceuticals Inc.

Company Profile: Oramed Pharmaceuticals Inc.
Market Cap (USD): $91.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

290. Immunic, Inc.

Company Profile: Immunic, Inc.
Market Cap (USD): $89.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

291. Karyopharm Therapeutics Inc.

Company Profile: Karyopharm Therapeutics Inc.
Market Cap (USD): $88.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

292. Werewolf Therapeutics, Inc.

Company Profile: Werewolf Therapeutics, Inc.
Market Cap (USD): $87.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

293. Agenus Inc.

Company Profile: Agenus Inc.
Market Cap (USD): $84.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

294. Inozyme Pharma, Inc.

Company Profile: Inozyme Pharma, Inc.
Market Cap (USD): $83.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

295. Inovio Pharmaceuticals, Inc.

Company Profile: Inovio Pharmaceuticals, Inc.
Market Cap (USD): $82.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

296. Reviva Pharmaceuticals Holdings, Inc.

Company Profile: Reviva Pharmaceuticals Holdings, Inc.
Market Cap (USD): $82.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

297. Leap Therapeutics, Inc.

Company Profile: Leap Therapeutics, Inc.
Market Cap (USD): $82.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

298. VistaGen Therapeutics, Inc.

Company Profile: VistaGen Therapeutics, Inc.
Market Cap (USD): $82.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

299. Ikena Oncology, Inc.

Company Profile: Ikena Oncology, Inc.
Market Cap (USD): $82.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

300. X4 Pharmaceuticals, Inc.

Company Profile: X4 Pharmaceuticals, Inc.
Market Cap (USD): $81.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology